WIDLIFRO
LIVE

Serial Number

79453463

Owner

Boehringer Ingelheim International GmbH

Filing Date

Jun 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

WIDLIFRO Trademark

Serial Number: 79453463

WIDLIFRO is a trademark filed by Boehringer Ingelheim International GmbH on June 8, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Boehringer Ingelheim International GmbH (4 trademarks)

Binger Strasse 173
Ingelheim 55218 , DE

Entity Type: 03

Trademark Details

Filing Date

June 8, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Filing History

LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 4, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 2, 2026 REPR